Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Press Releases
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
News type
All
Regulatory
Clinical
Conferences
Corporate
Finance
General Meeting
Product candidates
Science & Technology
Other
Subject
All
General Assembly
Company and personnel
GS010 - LUMEVOQ
GS030
Technologies
Other
31 May 2023
Annual General Meeting on June 21, 2023
10 May 2023
GenSight Biologics Announces the Filing of its 2022 Universal Registration Document and Reschedules its Annual General Meeting on June 21, 2023
10 March 2023
GenSight Biologics to Present at Upcoming Medical Conferences
28 Oct 2021 - 29 Oct 2021
Cell UK by Oxford’s Global, London (UK) & Virtual
25 Oct 2021 - 28 Oct 2021
BIO-Europe 2021, Virtual
15 Oct 2021 - 16 Oct 2021
Mitochondrial Diseases Conference 2021 by Mitocon, Virtual
19 Oct 2021 - 22 Oct 2021
28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT), Virtual
12 Oct 2021 - 14 Oct 2021
2021 ARM Cell & Gene Meeting on the Mesa, Carlsbad, CA (USA) & Virtual
08 Oct 2021 - 12 Oct 2021
39th Annual Scientific Meeting of the American Society of Retina Specialists (ASRS), San Antonio, TX (USA)
07 Oct 2021
OIS Retina Innovation Summit @ASRS, Austin, TX (USA)
1
2
3
4
5
6
…
17
View next 9 articles
Go back to the page of the page